Nevertheless, AF has been shown to enhance the efficacy of PD-L1 blockage in triple-negative breast cancer mouse models, indicating that this anti-inflammatory response might be valuable in combination with immunotherapy [75]. Here, CD274 is linked to triple-negative breast carcinoma.